Marino Garcia

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

DNTH

Current role

CEO, Board Member

2021-01-01–present

1 call Latest call 2026-03-09

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Dianthus Therapeutics, Inc. /DE/ (DNTH)	President and Chief Executive Officer	$630,000	—	—	$9,450,952	$519,750	$14,000	$10,614,702
2024	Dianthus Therapeutics, Inc. /DE/ (DNTH)	President and Chief Executive Officer	$600,000	—	—	$7,899,500	$330,000	$13,800	$8,843,300
2023	Dianthus Therapeutics, Inc. /DE/ (DNTH)	President and Chief Executive Officer	$174,863	—	—	—	$321,159	—	$496,022

Earnings-call appearances and filed executive appointments or departures, newest first.